Focus AreaDynAge

APPLICATION FORM: INTERNAL CALL 2014

Submit your application in English as a PDF document to by 31October 2014.

Please, use Arial11-point font (single-spacing) and comply with the provided structure. Reply to all fields in this application form. Instructions in grey and italic type fontare directions for filling out the application form and should be deleted.

(A) Consortium Overview and Information on the Group of Collaborating Applicants

1. Principal Investigators (PIs)

  • Please name two principal investigators, preferably one from the FU and one from the Charité, who will coordinate and report on the project (title, first name, surname, affiliation with address, e-mail, telephone and fax number, state of career[1]). PIs should be researchers that have been or are currently funded by DynAge.As within the third round of funding, only FU-PIs can be responsible for the administration of funds on behalf of the group, please name the FU-researcher as corresponding PI.

2. Collaborating Researchers

  • Please name all participating members of DynAge (title, first name, surname, affiliation, state of career1), i.e., researchers that have been or are currently funded by DynAge. Please name further regional, national, and/or international co-investigators in your group and their affiliations

3. Title of the Consortium

4. Keywords (max. 5)

5. Addressed Disease and Level of the Focus Area Matrix

  • Please activate with a double click the field of your research project in the Focus Area matrix of cooperation below.

Tumors / Cardio-Vascular Diseases / Degenerative Diseases of the Musculoskeletal System / Cognitive Disorders & Depression
Societal Level
Individual Level
Molecular Level

6. Extended Executive Summary of Consortium(maximum2000 words, Arial 11, single spaced)

  • Overall objectives, major research question(s), and knowledge gaps addressed, highlighting how the application fits into DynAge’s major research goals. Which disease group(s) is/are addressed? Which levels of the DynAge matrix of cooperation are addressed? How does the consortium address aging-related dynamics of disease and contrast different phases of the life span? How are early career scientists promoted? How is the consortium divided into subprojects? Which specific research questions are addressed by subprojects?Expected synergistic effects within the consortium?

7. Consortium

  • Please identify theDynAge-funded interdisciplinary research groups that merged into your proposed consortium, please name PIs, project titles, DynAge round of funding (1st : 2013/2014 and/or 2nd 2014/2015)

8. Envisioned Third-Party Funding for Consortium

Funding Agency:<e.g., DFG, BMBF, EU>

FundingProgram:<e.g., Klinische Forschergruppe (DFG)>

Envisioned timeline of preparation of application:<Please describe>

Planned amount of funding:<Please name full amount as well as planned shares for FU-researchers and Charité-researchers

(B) Requested Funding from DynAge (max 35.000,- EUR)

  • Please present a brief financial plan for the requested Focus Area funds. Please list types (staff and/or consumables) and amount of requested funding of both types for 2015 (Jan through Dec). Please list requested funds for staff in EUR.

(C) General References

(If applicable:List work cited in Extended Executive Summary)

(D) Brief CVs of all Participating Researchers

<Pleaseuse one form per researcher

Role in consortium / <Consortium PI, Consortium CoPI; Subproject PI; Subproject Co-PI; Coordinator, Investigator>
Full title, full name
Affiliation, department, division
E-mail address
Field of work / <Discipline, subdiscipline (e.g., medicine, oncology)
Year of PhD/MD
Career stage / < R1: First Stage Researcher (up to the point of PhD); R2 Recognized Researcher (PhD holders or equivalent who are not yet fully independent); R3 Established Researcher (researchers who have developed a level of independence; Nachwuchsgruppenleiter, W1-Prof); R4 Leading Researcher (researchers leading their research area or field, W2- and W3-Prof).>
Publications associated with work previously funded by DynAge (please list work accepted for publication only) / peer-reviewed journal articles, books, book chapters, conference papers, posters
Third-party funding activities (applications submitted/under review; funded projects; rejected projects) associated with work previously funded by DynAge or work in collaboration with DynAge-funded projects / Title of Consortium:
Consortium PIs:
Title of Subproject:
Own Role:
Funding Agency:
Funding Period:
Amount own Subproject:
Total Amount Consortium:
/or/
Title of Project:
Own Role:
Funding Agency:
Funding Period:
Total amount:
Publications 2009-2014 / peer-reviewed journal articles, books, book chapters>
Cumulative Journal Impact Factor (ISI):2009-2014(for publications in 2014, please use IF of 2013)
Number of times cited (please exclude citations of retracted publications) / <Please use one of the following and indicate which one you used: Web of Science, Google Scholar, Scopus, Harzing’s Publish or Perish. E.g.: Web of Science: n times cited; GoogleScholar: n times cited>
Third-party funding 2009-2014 / Title of Consortium:
Consortium PIs:
Title of Subproject:
Own Role:
Funding Agency:
Funding Period:
Amount own Subproject:
Total Amount Consortium:
/or/
Title of Project:
Own Role:
Funding Agency:
Funding Period:
Total amount:

[1]R1: First Stage Researcher (up to the point of PhD); R2 Recognized Researcher (PhD holders or equivalent who are not yet fully independent); R3 Established Researcher (researchers who have developed a level of independence; Nachwuchsgruppenleiter, W1 Prof); R4 Leading Researcher (researchers leading their research area or field, W2 und W3 Prof).